FIELD: immunology, biotechnology, peptides, pharmacy. SUBSTANCE: peptide shows the following amino acid sequence: ELDKWAS, LELDKWAS, ELDNWAS, ELNKWAS, LELDNWAS or LELNKWAS and promotes to the formation of antibodies. Peptide can be bound with a carrier as virus or viral protein. Peptide bound with a carrier is prepared by recombinant method. Antibody with HIV-1-neutralizing activity and secreted by mucosa envelope surface is prepared by immunization of human or animal. Invention ensures to develop a pharmaceutical agent promoting to the formation of antibodies to strains HIV-1 and/or clinical isolates. Invention can be used for preparing neutralizing antibodies raised to different strains and clinical isolates of HIV-1. EFFECT: improved method of peptide and antibody production. 17 cl, 9 dwg, 1 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT INFLUENZA VIRUS A | 2001 |
|
RU2280690C2 |
PEPTIDE-SIMULATOR OF HUMAN IMMUNODEFICIENCY TYPE-1 VIRUS PROTEIN GP41 CONSERVATIVE EPITOPE RECOGNIZED BY VIRUS-NEUTRALIZING MONOCLONAL ANTIBODY 2F5 (VARIANTS) | 2000 |
|
RU2179980C2 |
RAPID SELECTION METHOD FOR HIV GP-120 VARIANTS | 2012 |
|
RU2603732C2 |
CHIMERIC INFLUENZA VACCINES | 2021 |
|
RU2834969C1 |
VIRUS-LIKE PARTICLES WITH HIGH-DENSITY COATING FOR INDUCTION OF ANTIBODY EXPRESSION | 2017 |
|
RU2813282C2 |
RECOMBINANT VIRUS-LIKE PARTICLES (VLP) USING BOVINE IMMUNODEFICIENCY VIRUS GROUP-SPECIFIC ANTIGEN (GAG) PROTEIN | 2016 |
|
RU2734118C2 |
SAPOVIRUS VACCINES | 2022 |
|
RU2839769C2 |
RECOMBINANT CHIMERICAL nTBI POLYPEPTIDE-IMMUNOGEN WITH ABILITY TO INDUCE NEUTRALIZING ANTIBODIES TO TYPE 1 HUMAN IMMUNODEFICIENCY VIRUS AND INTENDED FOR USE AS COMPONENT OF VACCINE AGAINST HIV-1 | 2016 |
|
RU2642258C1 |
ROTAVIRAL PARTICLES WITH CHIMERIC SURFACE PROTEINS | 2014 |
|
RU2698049C2 |
RECOMBINANT VACCINE STRAIN FOR LIVE INTRANASAL VACCINE PROVIDING COMBINED PREVENTION OF INFLUENZA AND CORONAVIRUS INFECTIONS | 2022 |
|
RU2782531C1 |
Authors
Dates
2002-04-20—Published
1994-09-12—Filed